Quantitative EEG findings in patients with chronic renal failure

European Journal of Medical Research

Volumn 12, Issue 4, 2007, Pages 173-178

  Röhl, Jens Eric ^a   Harms, L ^a   Pommer, W ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b VIVANTES HOSPITAL   (Germany)

Author keywords

Anemia; Erythropoietin; Hemodialysis; Quantitative EEG; Uremic Encephalopathy

Indexed keywords

HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN; VITAMIN D;

ADULT; AGE DETERMINATION; AGED; ALPHA RHYTHM; ARTICLE; BLOOD PRESSURE; BRAIN DYSFUNCTION; BRAIN FUNCTION; BRAIN MAPPING; CENTRAL NERVOUS SYSTEM; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DELTA RHYTHM; DIAGNOSTIC VALUE; ELECTROENCEPHALOGRAM; FEMALE; FREQUENCY ANALYSIS; HEMODIALYSIS; HUMAN; INTERMETHOD COMPARISON; MALE; MENTAL DISEASE; QUANTITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE; TEMPORAL CORTEX; THETA RHYTHM; VITAMIN SUPPLEMENTATION;

ADULT; AGED; AGED, 80 AND OVER; BRAIN MAPPING; CASE-CONTROL STUDIES; ELECTROENCEPHALOGRAPHY; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 34248583281     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Brown WS, Marsh JT, Wolcott D, et al. Cognitive function, mood and P3 latency: effects of the amelioration of anemia in dialysis patients. Neuropsychologia 1991; 29: 35-45.
2. Brouns R, De Deyn PP. Neurological complications in renal failure: a review. Clin NeurolNeurosurg 2004; 107: 1-16.
3. Chui HC, Damasio AR. Progressive dialysis encephalopathy. J Neurol 1980; 222: 145-57.
4. Fraser CL, Arieff AI. Nervous system complications in uremia. Ann Intern Med 1988; 109: 143-53.
5. Grimm G, Stockenhuber F, Schneeweiss B, Madl C, Zeitlhofer J, Schneider B. Improvement of brain function in hemodialysis patients treated with erythropoietin. Kidney Int 1990; 38: 480-6.
6. Souheaver GT, Ryan JJ, De Wolfe AS. Neuropsychological patterns in uremia. J Clin Psychol 1982; 38: 490-496.
7. Pickett JL, Theberge DC, Brown WS, Schweitzer SU, Nissenson AR. Normalizing hematocrit in dialysis patients improves brain function. Am J Kidney Dis 1999; 33: 1122-1130.
8. Culebras A, Kline MD, Ross GS, Hodge CH, Cruz A. Quantitative EEG mapping of cerebral ischemia. Neurology 1986; 36 (Suppl 1): 321.
9. Sagales T, Gimeno V, Calzada MD, Casellas F, Macia D, Soriano MV. Brain mapping analysis in patients with hepatic encephalopathy. Brain Topography 1990; 2: 221-228.
10. Schellenberg R, Todorova A, Dimpfel W, Schober F. Pathophysiology and Psychopharmacology of Dementia - A new study design. Neuropsychobiology 1995; 32: 81-97.
11. Sagalés T, Gimeno V, Planella MJ, Raguer N, Bartolome J. Effects of rHuEPO on Q-EEG and event-related potentials in chronic renal failure. Kidney Int 1993; 44: 1109-1115.
12. Hart RP, Pederson JA, Czerwinski AW, Asams RL. Chronic renal failure, dialysis and neuropsychological function. J Clin Neuropsychol 1983; 5: 302-312.
13. Marsh TJ, Brown WS, Wolcott D, Landswerk J, Nissenson AR. Electrophysiological indices of CNS function in hemodialysis and CAPD. Kidney Int 1986; 15: 957-963.
14. Teschan PE, Ginn HE, Bourne JR. Quantitative indices of clinical uremia. Kidney Int 1979; 15: 676-697.
15. Grotta JC, Manner C, Pettigre LC, Yatsu FM. Red blood cell disorders and stroke. Stroke 1986; 17: 811-817.
16. DiPablo B, Diliberato L, Fiederling B, Catucci G, Bucciaralli S, Paolantonio L, Albertazzi A. Effects of uremia and dialysis on brain electrophysiology after recombinant erythropoietin treatment. ASAIO J 1992; 38: 477-480.
17. Marsh JT, Brown WS, Wolcott D, Carr CR, Harper R, Schweitzer SV, Nissenson AR. RHuEPO treatment improves brain and cognitive function of anemic dialysis patients. Kidney Int 1991; 39: 155-163.
18. Vanholder R, De Smet R, Glorieux G, Argiles A, Bourmeister U, Brunet P, et al., European Uremic Toxin Work Group. Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 2003; 63 (5): 1934-1943.
19. Dimpfel W, Schober F. Norepinephrine, EEG theta waves and sedation. Brain Pharmacology 2001; 1: 89-97.
20. Valentino RJ, Miselis RR, Pavcovich LA,: Pontine regulation of pelvic viscera: pharmacological target for pelvic visceral dysfunctions. TiPS 1999; 20: 253-260
21. Gomez CM, Vazquez M, Vaquero E, Lopez-Mendoza D, Cardoso MJ. Frequency analysis of the EEG during spatial selective attention. Int J Neurosci 1998; 95: 17-32.
22. Verstraeten E, Cluydts R. Attentional switching-related human EEG alpha oscillations. Neuroreport 2002; 13: 681-684.
23. Ehrenreich H, Aust C, Krampe H, Jahn H, Jacob S, Herrmann M, Siren A-L. Erythropoietin: Novel approaches to neuroprotection in human brain disease. Metabolic Brain Disease 2004; 19: 195-205.
24. Xenocostas A, Cheung WK, Farell F, Zakszewski C, Kelley M, Lutynski A, Crump M, Lipton JH, Kiss TL, Lau CY, Messner HA. The pharmacokinetics of erythropoietin in the cerebral fluid after intravenous administration of recombinant human erythropoietin. Eur J Clin Pharmacol 2005; 61: 189-195.